Showing 4891-4900 of 5771 results for "".
- Eylea Injection Prefilled Syringe Now Availablehttps://modernod.com/news/eylea-injection-prefilled-syringe-now-available/2477154/Regeneron announced that the Eylea (aflibercept) prefilled syringe is now available for doctors to order. The 2 mg, single-dose, sterilized prefilled syringe provides physicians with a new way to administer Eylea that requires fewer preparation steps compared to vials. Eylea is the
- Retina Rocks: Retina Image & Reference Library Now Available Onlinehttps://modernod.com/news/retina-rocks-retina-image-reference-library-now-available-online/2477152/Retina Rocks, a new online, collection of open-source retina teachings, is now available at retinarocks.org. The website includes 22,000 multimodal images and 3,700 annotated references that are organized alphabetically by topic into approximately 360 sections
- AAO and ASCRS Launch “Ophthovation” Joint Venture Business Innovation Conferenceshttps://modernod.com/news/aao-and-ascrs-launch-ophthovation-joint-venture-business-innovation-conferences/2477151/Two of the world’s largest ophthalmic organizations have finalized their joint venture “Ophthovation” to develop business conferences that accelerate innovation in ophthalmology. Called the Ophthovation Conference, the meeting will be held every year prior to the annual meetings of th
- Vision Innovation Partners Completes Acquisitions in Northern Marylandhttps://modernod.com/news/vision-innovation-partners-completes-acquisitions-in-northern-maryland/2477150/Vision Innovation Partners has announced it has acquired two practice groups and a surgery center in northern Maryland. The acquisition of Carroll Vision Center, Center for Total Eye Care, and Carroll County Surgery Center further expands Vision Innovation Partner
- Sight Sciences Appoints Erica Rogers to its Board of Directorshttps://modernod.com/news/sight-sciences-appoints-erica-rogers-to-its-board-of-directors/2477149/Sight Sciences announced the appointment of Erica Rogers to the company’s board of directors. Ms. Rogers, President and CEO of Silk Road Medical, is an experienced leader and entrepreneur in the medical device industry. She most recently led Silk Road Medical through FDA approval of
- Quantel Medical Receives FDA Approval for the Vitra 2 Laser for Retinal Photocoagulationhttps://modernod.com/news/quantel-medical-receives-fda-approval-for-the-vitra-2-laser-for-retinal-photocoagulation/2477148/Quantel Medical announced that it has received approval from the FDA for the Vitra 2 photocoagulator. The Vitra 2 includes all the key elements of the Vitra photocoagulator and features a wide a range of improv
- BVI Expands Vitreoretinal Surgery Presencehttps://modernod.com/news/bvi-expands-vitreoretinal-surgery-presence/2477146/BVI announced it has acquired Arcadophtha SARL (Arcad), a France-based ophthalmic company specializing in silicon oils, gases, and perfluorocarbons used in vitreoretinal surgery. Growth of the Arcad products will be accelerated through BVI’s commercial infra
- Nicox Signs Agreement for Zerviate in South Koreahttps://modernod.com/news/nicox-signs-agreement-for-zerviate-in-south-korea/2477143/Nicox announced the signature of an exclusive license agreement with Samil Pharmaceutical for the development and commercialization of Zerviate (cetirizine ophthalmic solution) 0.24% for the treatment of ocular itching associated with allergic conjunctivitis in South Korea. Samil Pharmaceutical i
- Novartis Harnessing AI in Amazon Partnership Aimed at Revamping Drug Manufacturing, Supplyhttps://modernod.com/news/novartis-harnessing-ai-in-amazon-partnership-aimed-at-revamping-drug-manufacturing-supply/2477142/Novartis announced Wednesday that it will work with Amazon’s cloud-computing unit to build a data and analytics platform that seeks to “re-invent” the way medicines are manufactured and delivered. “Four years ago, we started our journey with AWS (Amazon Web Servi
- Aerie Pharmaceuticals Submits Marketing Authorization Application for Roclanda in Europehttps://modernod.com/news/aerie-pharmaceuticals-submits-marketing-authorization-application-for-roclanda-in-europe/2477139/Aerie Pharmaceuticals announced that it has submitted the marketing authorization application (MAA) for Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005% with the European Medicines Agency (EMA). Should the MAA for Roclanda be accepted for review by the EMA, an opinion from t